Loading…
Bharat Immunological & Biological Corporation (BSE 524663)₹8.75+0.57%Pharmaceuticals
Bharat Immunological & Biological Corporation is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −8.9% against a peer median of 6.5%, and latest-quarter sales growth of −100.0% against a peer median of 2.4%. By market cap it is #6 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Vivimed Labs | 45 | — | −65.0 | — | — | 0.0 | 70 | −176 | −53.8 | — | vs BSE 524663 |
| Vasundhara Rasayans | 44 | 7.4 | 20.2 | 15.2 | 0.04 | 1.5 | 36 | 6 | 53.1 | 441.3 | vs BSE 524663 |
| Chandra Bhagat Pharma | 43 | 14.3 | 12.1 | 9.6 | 0.50 | 0.0 | 116 | 3 | 313.6 | — | vs BSE 524663 |
| Kabra Drugs | 42 | 8.4 | 20.8 | 18.3 | 0.02 | 0.0 | 93 | 5 | — | 167.5 | vs BSE 524663 |
| Vista Pharmaceuticals | 41 | — | −30.0 | −29.5 | 0.27 | 0.0 | 5 | −12 | −100.0 | — | vs BSE 524663 |
| Bharat Immunological & Biological Corporation | 38 | — | −8.9 | −17.7 | 0.94 | 0.0 | 45 | −17 | −100.0 | — | — |
| Rajnish Wellness | 38 | — | −9.0 | −6.7 | 0.00 | 0.0 | 143 | −6 | 1,667.0 | — | vs BSE 524663 |
| Sandu Pharmaceuticals | 36 | 19.7 | 6.5 | 4.1 | 0.01 | 2.2 | 70 | 2 | 19.9 | −90.6 | vs BSE 524663 |
| Gujarat Terce Laboratories | 35 | 16.4 | 39.3 | 30.2 | 0.13 | 0.0 | 47 | 2 | −17.1 | — | vs BSE 524663 |
| Roopa Industries | 35 | 549.5 | 15.0 | 23.2 | 1.75 | 0.0 | 128 | 0 | 1.0 | −434.9 | vs BSE 524663 |
| Medi Caps | 32 | — | −2.6 | −2.6 | 0.00 | 0.0 | 12 | −3 | 3.7 | — | vs BSE 524663 |
| Peer median | 38 | 15.3 | 6.5 | 6.9 | 0.08 | 0.0 | 70 | 0 | 2.4 | 38.4 |
Listed companies closest to Bharat Immunological & Biological Corporation in Pharmaceuticals include Vivimed Labs, Vasundhara Rasayans, Chandra Bhagat Pharma, Kabra Drugs, Vista Pharmaceuticals, Rajnish Wellness, Sandu Pharmaceuticals, Gujarat Terce Laboratories.
Vivimed Labs, with a market cap of ₹44.77 Cr.
Bharat Immunological & Biological Corporation's return on capital employed is −8.9%, below the peer median of 6.5%.